Genes, Free Full-Text
Por um escritor misterioso
Descrição
KMT2A (Lysine methyltransferase 2A) is a member of the epigenetic machinery, encoding a lysine methyltransferase responsible for the transcriptional activation through lysine 4 of histone 3 (H3K4) methylation. KMT2A has a crucial role in gene expression, thus it is associated to pathological conditions when found mutated. KMT2A germinal mutations are associated to Wiedemann–Steiner syndrome and also in patients with initial clinical diagnosis of several other chromatinopathies (i.e., Coffin–Siris syndromes, Kabuki syndrome, Cornelia De Lange syndrome, Rubinstein–Taybi syndrome), sharing an overlapping phenotype. On the other hand, KMT2A somatic mutations have been reported in several tumors, mainly blood malignancies. Due to its evolutionary conservation, the role of KMT2A in embryonic development, hematopoiesis and neurodevelopment has been explored in different animal models, and in recent decades, epigenetic treatments for disorders linked to KMT2A dysfunction have been extensively investigated. To note, pharmaceutical compounds acting on tumors characterized by KMT2A mutations have been formulated, and even nutritional interventions for chromatinopathies have become the object of study due to the role of microbiota in epigenetic regulation.
PDF) Genome evolution in bacteria: order beneath chaos
Free Google Slides and PowerPoint Templates about Genetics
Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia
Limitations of alignment-free tools in total RNA-seq
Highly Efficient and Marker-free Genome Editing of Human
Cs 1.6 Lj Cj Script - Colaboratory
Race and Genetic Ancestry in Medicine — A Time for Reckoning with
Heredity - Transcription, Translation, Genetics
Small Antisense DNA-Based Gene Silencing Enables Cell-Free